Elanix Biotechnologies AG
ELN | F
Overview
Corporate Details
- ISIN(s):
- DE000A0WMJQ4
- LEI:
- 391200SYNFFL0NPAJK90
- Country:
- Germany
- Address:
- Hanauer Landstrasse 291, 60314 Frankfurt am Main
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
Elanix Biotechnologies is a tissue regeneration company. We develop and commercialize products for acute wound care, dermatological and gynecological applications, as well as providing cell technology services. The company was founded in 2012 as a spin-off from the University Hospital of Lausanne (CHUV), Switzerland, to commercialize a patented progenitor cell technology. Progenitor cells are fully differentiated yet immunologically neutral cells that are very potent inducers of tissue growth and healing. Elanix owns GMP certified Master and Working cell banks containing vast quantities of cells. The Company is headquartered in Epalinges, Switzerland with offices in Hamburg and listed on the Frankfurt stock exchange under the symbol ELN.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2023-02-14 10:05 |
Board/Management Change
Elanix Biotechnologies AG: RESIGNATION AND NOMINATION IN THE SUPERVISORY BOARD
|
English | 5.1 KB | |
| 2022-12-21 18:30 |
Declaration of Voting Results & Voting Rights Announcements
|
German | 4.6 KB | |
| 2022-12-19 12:30 |
Declaration of Voting Results & Voting Rights Announcements
|
German | 14.0 KB | |
| 2022-12-06 13:00 |
Declaration of Voting Results & Voting Rights Announcements
|
German | 14.2 KB | |
| 2022-12-05 10:15 |
Declaration of Voting Results & Voting Rights Announcements
|
German | 13.7 KB | |
| 2022-12-02 15:15 |
Declaration of Voting Results & Voting Rights Announcements
|
German | 14.0 KB | |
| 2020-02-27 12:19 |
Board/Management Change
ELANIX BIOTECHNOLOGIES AG: RESIGNATION AND NOMINATION IN THE SUPERVISORY BOARD …
|
English | 4.8 KB | |
| 2019-10-03 10:34 |
Report Publication Announcement
|
English | 2.0 KB | |
| 2019-08-21 16:49 |
Report Publication Announcement
|
English | 2.0 KB | |
| 2019-08-19 16:58 |
Report Publication Announcement
|
English | 2.0 KB | |
| 2019-07-26 13:51 |
Declaration of Voting Results & Voting Rights Announcements
|
English | 14.0 KB | |
| 2019-07-23 16:59 |
Declaration of Voting Results & Voting Rights Announcements
|
English | 14.0 KB | |
| 2019-07-22 10:17 |
Declaration of Voting Results & Voting Rights Announcements
|
English | 14.0 KB | |
| 2019-06-25 14:03 |
Declaration of Voting Results & Voting Rights Announcements
|
English | 13.9 KB | |
| 2019-06-25 13:57 |
Declaration of Voting Results & Voting Rights Announcements
|
English | 13.9 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
PREDILIFE | France | ALPRE | |
|
PROSPEX ENERGY PLC | United Kingdom | PXEN | |
|
Prostatype Genomics AB | Sweden | PROGEN | |
|
Psych Capital Plc | United Kingdom | PSY | |
|
Pure Biologics S.A. | Poland | PUR | |
|
Puretech Health PLC | United States of America | PRTC | |
|
Purple Biotech Ltd. | Israel | PPBT | |
|
QLife Holding AB | Sweden | QLIFE | |
|
Quantum Genomics | France | ALQGC | |
|
QUIA PHARMA AB | Sweden | QUIA |